2-Amino-2',5-dichlorobenzophenoneCAS# 2958-36-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 2958-36-3 | SDF | Download SDF |
PubChem ID | 18069 | Appearance | Powder |
Formula | C13H9Cl2NO | M.Wt | 266 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2-amino-5-chlorophenyl)-(2-chlorophenyl)methanone | ||
SMILES | C1=CC=C(C(=C1)C(=O)C2=C(C=CC(=C2)Cl)N)Cl | ||
Standard InChIKey | KWZYIAJRFJVQDO-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C13H9Cl2NO/c14-8-5-6-12(16)10(7-8)13(17)9-3-1-2-4-11(9)15/h1-7H,16H2 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
2-Amino-2',5-dichlorobenzophenone Dilution Calculator
2-Amino-2',5-dichlorobenzophenone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.7594 mL | 18.797 mL | 37.594 mL | 75.188 mL | 93.985 mL |
5 mM | 0.7519 mL | 3.7594 mL | 7.5188 mL | 15.0376 mL | 18.797 mL |
10 mM | 0.3759 mL | 1.8797 mL | 3.7594 mL | 7.5188 mL | 9.3985 mL |
50 mM | 0.0752 mL | 0.3759 mL | 0.7519 mL | 1.5038 mL | 1.8797 mL |
100 mM | 0.0376 mL | 0.188 mL | 0.3759 mL | 0.7519 mL | 0.9398 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Sakuranetin
Catalog No.:BCN5199
CAS No.:2957-21-3
- (E)-N-Caffeoylputrescine
Catalog No.:BCC8391
CAS No.:29554-26-5
- Negletein
Catalog No.:BCN8085
CAS No.:29550-13-8
- Olivil
Catalog No.:BCN5198
CAS No.:2955-23-9
- Eupatoletin
Catalog No.:BCN3605
CAS No.:29536-44-5
- MNI-caged-L-glutamate
Catalog No.:BCC7086
CAS No.:295325-62-1
- Valerosidate
Catalog No.:BCN6750
CAS No.:29505-31-5
- Cypellocarpin C
Catalog No.:BCN7556
CAS No.:294856-66-9
- Narciclasine
Catalog No.:BCN4732
CAS No.:29477-83-6
- Ganoderic acid Z
Catalog No.:BCN2440
CAS No.:294674-09-2
- L 006235
Catalog No.:BCC2361
CAS No.:294623-49-7
- Ticarcillin sodium
Catalog No.:BCC4737
CAS No.:29457-07-6
- Gynuramide II
Catalog No.:BCN5200
CAS No.:295803-03-1
- Friedelin 3,4-lactone
Catalog No.:BCN6449
CAS No.:29621-75-8
- 13-Oxo-9E,11E-octadecadienoic acid
Catalog No.:BCN8173
CAS No.:29623-29-8
- 2-Aminothiazol-4-acetic acid
Catalog No.:BCC8556
CAS No.:29676-71-9
- Ethynodiol diacetate
Catalog No.:BCC4483
CAS No.:297-76-7
- Oxyresveratrol
Catalog No.:BCN5201
CAS No.:29700-22-9
- dihydrokaempferol
Catalog No.:BCC8191
CAS No.:5150-32-3
- DOB hydrochloride
Catalog No.:BCC5947
CAS No.:29705-96-2
- Methyl chlorogenate
Catalog No.:BCC9042
CAS No.:29708-87-0
- Clopidol
Catalog No.:BCC8918
CAS No.:2971-90-6
- Dihydro-β-erythroidine hydrobromide
Catalog No.:BCC7341
CAS No.:29734-68-7
- Apigenin-7-glucuronide
Catalog No.:BCN5326
CAS No.:29741-09-1
Conformations of substituted benzophenones.[Pubmed:18369292]
Acta Crystallogr B. 2008 Apr;64(Pt 2):206-16.
The inclination of the two aryl rings (ring twists) in a series of benzophenone molecules has been examined. For each structure the dihedral angle (between the planes of the two sets of six aromatic C atoms) relates to both the steric considerations of the single molecule and the packing forces related to the crystal structure. Six new benzophenone structures are incorporated into the study including 2,2'-dihydroxy-4,4'-dimethoxybenzophenone (I), C(15)H(14)O(5), that appears to have the smallest reported twist angle, 37.85 (5) degrees , of any substituted benzophenone reported to date. Three further benzophenones, 4,4'-bis(diethylamino)benzophenone (II), C(21)H(28)N(2)O, 3,4-dihydroxybenzophenone (III), C(13)H(10)O(3), and 3-hydroxybenzophenone (IV), C(13)H(10)O(2), have similar ring twists [49.83 (5), 49.84 (5) and 51.61 (5) degrees , respectively] that are comparable with the value of 54 degrees found for the orthorhombic form of unsubstituted benzophenone. 4-Chloro-4'-hydroxybenzophenone (V), C(13)H(9)ClO(2), has a ring twist of 64.66 (8) degrees that is close to the value of 65 degrees found in the metastable monoclinic form of unsubstituted benzophenone and 2-amino-2',5-dichlorobenzophenone (VI), C(13)H(9)Cl(2)NO(2), has a large ring twist of 83.72 (6) degrees . Comparisons with a further 98 substituted benzophenone molecules from the Cambridge Structural Database (CSD) have been made.
[Detection of lorazepam and lormetazepam metabolites in urine using thin-layer chromatography].[Pubmed:9560883]
Soud Lek. 1998 Jan;43(1):2-4.
The determination of benzodiazepine derivatives lorazepam and lormetazepam in urine is based on detection of their metabolites 2-amino-2',5-dichlorobenzophenone and 2-methylamino-2'5-dichlorbenzophenone in hydrolyzed urine. Both substances are structurally very similar to the metabolites of diazepam 2-amino-5-chlorbenzophenone and 2-methylamino-5-chlorbenzophenone and their mobility on thin layer chromatograms is similar as well. This could cause their confusion and misinterpretation of the results. Therefore suitable combination of mobile phases and thin layer plates was sought in this study for the unambiguous identification of respective benzophenones by thin layer chromatography.
Separation and determination of aminohalogenbenzophenones by high-performance liquid chromatography with electrochemical detection.[Pubmed:1400781]
J Chromatogr. 1992 Jul 1;578(1):146-51.
A high-performance liquid chromatographic method with electrochemical detection has been developed for the determination of three aminohalogenbenzophenones: 2-amino-2',5-dichlorobenzophenone, 2-amino-5-chlorobenzophenone and 2-amino-5-bromo-2'-fluorobenzophenone, metabolites of benzodiazepinooxazoles and other psychotropic drugs. A mobile phase of methanol-water (65:35), containing 5 mM KH2PO4 appeared to be the optimal when a 4-microns, 60-A Nova-Pak C18 column and a flow-rate of 0.75 ml/min (130 bar) were used. The temperature was optimized at 30 degrees C. The amperometric detector, equipped with glassy carbon electrode, was operated at 1.3 V versus Ag/AgCl in the DC mode. The method was applied to the determination of these compounds at two concentration levels: ppm and ppb (ng/cm3) using 2-amino-5-chlorobenzophenone as internal standard. The limit of determination was 750 pg/ml of biological fluid for each compound, and recoveries greater than 97% were obtained for spiked samples of urine and serum, using C18 Sep-Pak cartridges in the sample clean-up procedure.